[O3] Oral Session 3"Cancer 1"

[O3-3] Oncolytic virus-infected-mesenchymal stem cells contribute to the enhanced antitumor immunity

^○Shigeru Matsumura¹, Patricia Angela Alvero Sibal^1,2, Itzel Villalobos Bustos¹, Mohamed Abdelmoneim^1,2,3, Mona Al Hussein Mostafa Aboalela^1,2,4, Nobuaki Mukoyama⁵, Yoshinori Naoe¹, Hideki Kasuya¹ (1.Cancer Immune Therapy Research Center, International Medical Education, Nagoya University, Graduate School of Medicine, 2.Department of Surgery II, Nagoya University, Graduate School of Medicine, 3.Microbiol., Vet. Med., Zagazig Univ., Egypt, 4.Med. Microbiol. and Immun., Zagazig Univ., Egypt, 5.Otol. Grad. Sch. Med., Nagoya Univ.)